NCT03673111View on ClinicalTrials.gov

Study of the Gut Hormone Analogue Y14 in Adult Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

April 10, 2017

Primary Completion Date

February 13, 2019

Study Completion Date

February 13, 2019

Conditions
Diabetes MellitusObesity
Interventions
DRUG

Y14

Gut hormone analogue

DRUG

Placebo

0.9% saline

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit, Leeds

Sponsors
All Listed Sponsors
collaborator

Medical Research Council

OTHER_GOV

collaborator

Covance

INDUSTRY

lead

Imperial College London

OTHER